Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Structural Variants Involving MLLT10/AF10 Are Associated with Adverse Outcome in AML Regardless of the Partner Gene - a COG/Tpaml Study

Rhonda E. Ries, MA, Amanda R. Leonti, MS, Timothy Junius Triche, Jr., PhD, Robert B. Gerbing, Betsy A Hirsch, PhD, Susana C. Raimondi, PhD, Jenny L. Smith, MSc, MD, Todd M Cooper, DO, Jason E. Farrar, MD, Aniruddha J. Deshpande, E. Anders Kolb, MD, Alan S Gamis, MD MPH, Richard Aplenc, MD PhD, Todd A. Alonzo, PhD, Soheil Meshinchi, MD PhD

Blood (2019) 134 (Supplement_1): 461.

https://doi.org/10.1182/blood-2019-125943

Published: 2019

Journal Articles

A Personalized Prediction Model to Risk Stratify Patients with Acute Myeloid Leukemia (AML) Using Artificial Intelligence

Blood (2019) 134 (Supplement_1): 2091.

https://doi.org/10.1182/blood-2019-128066

Published: 2019

Journal Articles

Predicting Response to Hypomethylating Agents in Patients with Myelodysplastic Syndromes (MDS) Using Artificial Intelligence (AI)

Nathan Radakovich, BA, Mikkael A. Sekeres, MD MS, Cameron Beau Hilton, BA, Sudipto Mukherjee, MD PhD MPH, Jacob Shreve, MD MS, Yazan Rouphail, Rachel Shirley, Vera Adema, PhD, Hassan Awada, MD, Anjali S. Advani, MD, Cassandra M Kerr, MS, Yasunobu Nagata, MD PhD, Yihong Guan, PhD, Teodora Kuzmanovic, BA, Metis Hasipek, PhD, Babal K. Jha, PhD, Jaroslaw P. Maciejewski, MD PhD, Aziz Nazha, MD

Blood (2019) 134 (Supplement_1): 2089.

https://doi.org/10.1182/blood-2019-126275

Published: 2019

Journal Articles

CD70-Specific CAR T Cells Have Potent Activity Against Acute Myeloid Leukemia (AML) without HSC Toxicity

Tim Sauer, MD, Kathan Parikh, Sandhya Sharma, Bilal Omer, MD, Stephen Gottschalk, MD, Cliona M. Rooney, PhD

Blood (2019) 134 (Supplement_1): 1932.

https://doi.org/10.1182/blood-2019-125534

Published: 2019

Journal Articles

Mutational Type and Configuration of an Individual Gene May Differentially Impact the Clinical and Phenotypic Features

Yasunobu Nagata, MD PhD, Hideki Makishima, MD PhD, Cassandra M Kerr, MS, Bhumika J. Patel, MD, Hassan Awada, Vera Adema, PhD, Valeria Visconte, PhD, Sudipto Mukherjee, MD PhD MPH, Thomas Laframboise, PhD, Aziz Nazha, MD, Tomas Radivoyevitch, PhD, Mikkael A. Sekeres, MD MS, Seishi Ogawa, MD PhD, Jaroslaw P. Maciejewski, MD PhD

Blood (2019) 134 (Supplement_1): 2992.

https://doi.org/10.1182/blood-2019-128893

Published: 2019

Journal Articles

Determinants of "Fitness" for Intensive Therapy Among Acute Myeloid Leukemia (AML) Patients

Abby Statler, PhDMPH, Brian P. Hobbs, PhD, Tomas Radivoyevitch, PhD, Caitlin Siebenaller, PharmD, Sudipto Mukherjee, MD PhD MPH, Anjali S. Advani, MD, Aaron T. Gerds, MD MS, Aziz Nazha, MD, Bhumika J. Patel, MD, Hetty E. Carraway, MD MBA, Mikkael A. Sekeres, MD MS

Blood (2019) 134 (Supplement_1): 3836.

https://doi.org/10.1182/blood-2019-128853

Published: 2019

Journal Articles

Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia (AML)

Blood (2019) 134 (Supplement_1): 4599.

https://doi.org/10.1182/blood-2019-131011

Published: 2019

Journal Articles

Pattern of Somatic Mutation Changes from Diagnosis to Relapse Following Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)

Sanghee Hong, MD, Cassandra M Kerr, MS, Lisa Rybicki, MS, Valeria Visconte, PhD, Jibran Durrani, Hassan Awada, MD, Betty K. Hamilton, MD, Ronald Sobecks, MD, Matt Kalaycio, MD, Aaron T. Gerds, MD MS, Mikkael A. Sekeres, MD MS, Hetty E. Carraway, MD MBA, Sudipto Mukherjee, MD PhD MPH, Anjali S. Advani, MD, Aziz Nazha, MD, Navneet S. Majhail, MD MS, Jaroslaw P. Maciejewski, MD PhD

Blood (2019) 134 (Supplement_1): 2716.

https://doi.org/10.1182/blood-2019-130352

Published: 2019

Journal Articles

Cell Type-Specific Deregulation of Polypyrimidine Tract- Binding Proteins (PTBPs) Drive Aberrant Splicing in Multiple Myeloma (MM) and Acute Myeloid Leukemia (AML)

Sophia Adamia, PhD, Sigitas J Verselis, PhD, Teru Hideshima, MD PhD, Michael P. Chu, MD, Shruti Bhatt, PhD, David P. Steensma, MD, Daniel J Deangelo, Richard M. Stone, MD, Daniel G. Tenen, MD, Linda M. Pilarski, PhD, James D. Griffin, MD, Kenneth Anderson, MD

Blood (2018) 132 (Supplement 1): 3895.

https://doi.org/10.1182/blood-2018-99-118501

Published: 2018

Journal Articles

Honeur (Heamatology Outcomes Network in Europe): A Federated Model to Support Real World Data Research in Hematology

Kristina Bardenheuer, MSc Epi, Alun Passey, PhDTranslational Oncology, Maria d'Errico, PhDPhysics, Barbara Millier, MBA, Carine Guinard-Azadian, MD, Johan Aschan, MD PhD, Michel van Speybroeck, MSc

Blood (2018) 132 (Supplement 1): 4839.

https://doi.org/10.1182/blood-2018-99-111093

Published: 2018

Journal Articles

Successful Simultaneous Screening of Sickle Cell Disease, HIV and Tuberculosis in Rural Guinea Bissau, West Africa through Rapid Tests and a Standardized Clinical Questionnaire: An Outreach Program Due to a Public-Private Partnership

Federica Menzato, MD, Luca Bosa, MD, Armando Sifna, MD, Luisa Da Silva, MD, Elena Gasperoni, Maddalena Martella, Mamadu Saliu Sanha, Alfa Mustik, Liviana Da Dalt, Prof., Fabio Riccardi, MD, Raffaella Colombatti, MD PhD

Blood (2018) 132 (Supplement 1): 4715.

https://doi.org/10.1182/blood-2018-99-119006

Published: 2018

Journal Articles

"in the Patients' Hands"- a Structured Survey of Patient Voices to Prioritise Research Questions in Rare Inherited Anaemias: The James Lind Alliance Priority Setting Partnership

Jenny Welch, Nick Meade, Dominic Messenger, Amy Hunter, Anupama Rao, MD, Subarna Chakravorty, Rachel Wearmouth, Anju Chalin, Kristina Staley, Sheela Upadhyaya, Irene Roberts, MD, Noemi Roy, MBBCH, MD

Blood (2018) 132 (Supplement 1): 5876.

https://doi.org/10.1182/blood-2018-99-115404

Published: 2018

Journal Articles

Evaluating the Evidence for Long-Term Benefit from Specialty Centers Versus Real World for MDS Patients Treated with HMA

Sudipto Mukherjee, MD PhD MPH, Tomas Radivoyevitch, PhD, Brian P. Hobbs, PhD, Xuefei Jia, MS, Rami S. Komrokji, MD, David P. Steensma, MD, Amy E. DeZern, MD, Gail J. Roboz, MD, Guillermo Garcia-Manero, MD, Jaroslaw P. Maciejewski, Aziz Nazha, Mikkael A. Sekeres, MD MS

Blood (2018) 132 (Supplement 1): 3095.

https://doi.org/10.1182/blood-2018-99-119146

Published: 2018

Journal Articles

Targeting Transition: a Novel Partnership with Family Medicine to Enhance Quality of Care and Outcomes for Adolescents and Young Adults with Sickle Cell Disease

Emily Riehm Meier, MD MSHS, Amy Dawson, MD, Natalie Duncan, MPH, Dennis O'Brien, MD, Anne Greist, MD

Blood (2017) 130 (Supplement 1): 2077.

https://doi.org/10.1182/blood.V130.Suppl_1.2077.2077

Published: 2017

Journal Articles

Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research

Patrick T. McGann, Arielle G. Hernandez, Russell E. Ware

Blood (2017) 129 (2): 155–161.

https://doi.org/10.1182/blood-2016-09-702324

Published: 2017

Journal Articles

A Novel Health Informatics Tool to Improve Caregiver Activation: Findings from Pediatric BMT in a Hospital-Based Setting

Lyndsey Runaas, MD, Evan Bischoff, BS, Flora Hoodin, PhD, Rachel Kentor, MS, Lauren Ostarello, MS, Sajjad Seyedsalehi, MS, David Hanauer, MD MS, Sung Won Choi, MS, MD

Blood (2016) 128 (22): 2382.

https://doi.org/10.1182/blood.V128.22.2382.2382

Published: 2016

Journal Articles

Patient Reported Outcomes to Assess Quality of Hemophilia Care in North India - Results of a Global Partnership

Akshat Jain, MD MPH, Sudhir Mehta, MD, Mrinal Joshi, MD, Kapil Garg, MD, Laxmi Kant Goyal, MD, Aric Parnes, MD, Hasan Al-Sayegh, MPH, Clement Ma, PhD, Ellis J. Neufeld, MD PhD

Blood (2016) 128 (22): 3587.

https://doi.org/10.1182/blood.V128.22.3587.3587

Published: 2016

Journal Articles

Blood at 70: its roots in the history of hematology and its birth

Barry S. Coller

Blood (2015) 126 (24): 2548–2560.

https://doi.org/10.1182/blood-2015-09-659581

Published: 2015

Journal Articles

Demographic Features of a Mixed Urban/Rural Adult Sickle Cell Population:Opportunities and Challenges for Improving Health Care

Amauri Bowman, Sydney Taylor, Pritam Bora, Hongyan Xu, PhD, Leigh Wells, MS, Latanya Bowman, BS, Nadine Barrett, MS, Richard Lottenberg, MD, E. Leila Jerome Clay, MD, Betty Pace, MD, Matthew Lyon, MD, Robert Gibson, PhD, Abdullah Kutlar, MD

Blood (2015) 126 (23): 5594.

https://doi.org/10.1182/blood.V126.23.5594.5594

Published: 2015

Journal Articles

Statewide Geographic Variation and Impact of Center Expertise upon Outcomes for Adults with Acute Myeloid Leukemia (AML) in North Carolina

Ashley T Freeman, MD, Anne Marie Meyer, PhD, Andrew B Smitherman, MD, Lei Zhou, MSPH, Ethan M Basch, MD MSc, Thomas C. Shea, MD, William A. Wood, MD MPH

Blood (2015) 126 (23): 4479.

https://doi.org/10.1182/blood.V126.23.4479.4479

Published: 2015

NARROW

Structural Variants Involving MLLT10/AF10 Are Associated with Adverse Outcome in AML Regardless of the Partner Gene - a COG/Tpaml Study

A Personalized Prediction Model to Risk Stratify Patients with Acute Myeloid Leukemia (AML) Using Artificial Intelligence

Predicting Response to Hypomethylating Agents in Patients with Myelodysplastic Syndromes (MDS) Using Artificial Intelligence (AI)

CD70-Specific CAR T Cells Have Potent Activity Against Acute Myeloid Leukemia (AML) without HSC Toxicity

Mutational Type and Configuration of an Individual Gene May Differentially Impact the Clinical and Phenotypic Features

Determinants of "Fitness" for Intensive Therapy Among Acute Myeloid Leukemia (AML) Patients

Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia (AML)

Pattern of Somatic Mutation Changes from Diagnosis to Relapse Following Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS)

Cell Type-Specific Deregulation of Polypyrimidine Tract- Binding Proteins (PTBPs) Drive Aberrant Splicing in Multiple Myeloma (MM) and Acute Myeloid Leukemia (AML)

Honeur (Heamatology Outcomes Network in Europe): A Federated Model to Support Real World Data Research in Hematology

Successful Simultaneous Screening of Sickle Cell Disease, HIV and Tuberculosis in Rural Guinea Bissau, West Africa through Rapid Tests and a Standardized Clinical Questionnaire: An Outreach Program Due to a Public-Private Partnership

"in the Patients' Hands"- a Structured Survey of Patient Voices to Prioritise Research Questions in Rare Inherited Anaemias: The James Lind Alliance Priority Setting Partnership

Evaluating the Evidence for Long-Term Benefit from Specialty Centers Versus Real World for MDS Patients Treated with HMA

Targeting Transition: a Novel Partnership with Family Medicine to Enhance Quality of Care and Outcomes for Adolescents and Young Adults with Sickle Cell Disease

Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research

A Novel Health Informatics Tool to Improve Caregiver Activation: Findings from Pediatric BMT in a Hospital-Based Setting

Patient Reported Outcomes to Assess Quality of Hemophilia Care in North India - Results of a Global Partnership

Blood at 70: its roots in the history of hematology and its birth

Demographic Features of a Mixed Urban/Rural Adult Sickle Cell Population:Opportunities and Challenges for Improving Health Care

Statewide Geographic Variation and Impact of Center Expertise upon Outcomes for Adults with Acute Myeloid Leukemia (AML) in North Carolina

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only